3

PRIMARY DOCUMENT

Company: Crinetics Pharmaceuticals, Inc.
Filed: July 17, 2018
Period of Report: July 17, 2018
Accession Number: 0001012975-18-000919

View Document ↗ View on SEC.gov ↗